doi: 10.1016/0006-291x(85)90922-2.
Stoichiometry of binding of high molecular weight kininogen to factor XI/XIa
- PMID: 3936495
- DOI: 10.1016/0006-291x(85)90922-2
Item in Clipboard
Stoichiometry of binding of high molecular weight kininogen to factor XI/XIa
Biochem Biophys Res Commun.
.
Abstract
Factor XI is a dimeric protein and circulates in plasma complexed with high molecular weight kininogen (HMWK). We investigated the binding of HMWK to factor XIa utilizing two active site directed fluorescent probes: nitrobenzoxadiazole aminopentyl methylphosphonofluoridate for serine and dansyl-glu-gly-arg-chloromethyl ketone for histidine. In the presence of saturating amounts of HMWK, the fluorescence of factor XIa-fluorophore was quenched by approximately 28% for each probe. Titrations of the fluorescent factor XIa with HMWK revealed that each subunit of factor XIa binds one molecule of HMWK with a Kd approximately 3.4 X 10(-8)M.
Similar articles
-
Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function.J Biol Chem. 1985 Sep 5;260(19):10856-63. J Biol Chem. 1985. PMID: 3875612
-
Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.Blood. 1989 Jul;74(1):244-51. Blood. 1989. PMID: 2665835
-
Conformation of high molecular weight kininogen: effects of kallikrein and factor XIa cleavage.Biochem Biophys Res Commun. 1989 Jan 16;158(1):72-9. doi: 10.1016/s0006-291x(89)80178-0. Biochem Biophys Res Commun. 1989. PMID: 2783551
-
Role of high molecular weight kininogen in contact activation.Semin Thromb Hemost. 1987 Jan;13(1):15-24. doi: 10.1055/s-2007-1003472. Semin Thromb Hemost. 1987. PMID: 2436301 Review. No abstract available.
-
[The so-called "contact" system of plasma: consequences of the activation of the Hageman factor].Ann Biol Clin (Paris). 1988;46(3):185-9. Ann Biol Clin (Paris). 1988. PMID: 3044204 Review. French.
Cited by
-
Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.J Biol Chem. 2008 Mar 14;283(11):6696-705. doi: 10.1074/jbc.M707234200. Epub 2008 Jan 11. J Biol Chem. 2008. PMID: 18192270 Free PMC article.
-
Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):152-6. doi: 10.1073/pnas.89.1.152. Proc Natl Acad Sci U S A. 1992. PMID: 1729682 Free PMC article.
-
Bradykinin formation. Plasma and tissue pathways and cellular interactions.Clin Rev Allergy Immunol. 1998 Winter;16(4):403-29. doi: 10.1007/BF02737659. Clin Rev Allergy Immunol. 1998. PMID: 9926288 Review. No abstract available.
-
Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease.J Clin Invest. 1987 Jun;79(6):1874-8. doi: 10.1172/JCI113030. J Clin Invest. 1987. PMID: 3034984 Free PMC article.
-
Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies.J Clin Invest. 1986 Dec;78(6):1631-7. doi: 10.1172/JCI112756. J Clin Invest. 1986. PMID: 3491093 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
